<DOC>
	<DOCNO>NCT00638326</DOCNO>
	<brief_summary>The purpose study determine whether administration 150 mg clopidogrel effective reduce one-year incidence thromboischemic event patient high on-clopidogrel platelet reactivity compare 75 mg clopidogrel elective percutaneous coronary intervention .</brief_summary>
	<brief_title>Doubling Maintenance Dose Clopidogrel Patients With High On-Clopidogrel Platelet Reactivity</brief_title>
	<detailed_description />
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>Clopidogrelna√Øve stable angina pectoris ( CCS IIII ) Coronary angiography reveals significant DE NOVO coronary stenosis ( diameter stenosis great 50 % two independent projection ) feasible ad hoc stent implantation Acute coronary syndrome ( STEMI , NSTEMI unstable angina ) Administration clopidogrel/ticlopidine/coumarin past 6 week Contraindication antiplatelet therapy Significant LM stenosis PCI due instent restenosis Lesion locate bypass graft Stroke past one year Reduced life expectancy</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Clopidogrel , thrombosis , Percutaneous Transluminal Coronary Angioplasty , stent</keyword>
</DOC>